Children's Cancer Group, China
Clinical trials sponsored by Children's Cancer Group, China, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New trial aims to boost survival in kids with rare lymphoma Results expected Dec 2026 (estimated)
-
New combo therapy aims to beat childhood lymphoma
Disease control Recruiting nowThis study is testing whether adding the drug rituximab early and intensively to a strong chemotherapy regimen can improve outcomes for children and teens with aggressive B-cell non-Hodgkin lymphoma. About 87 participants will receive the combination therapy. The goal is to see i…
Phase 2/3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New trial aims to boost survival in kids with rare lymphoma
Disease control Recruiting nowThis study compares two different ways of giving methotrexate (a chemotherapy drug) to children and teens newly diagnosed with T-cell lymphoblastic lymphoma, a rare cancer of the immune system. About 200 participants will be randomly assigned to one of two treatment plans to see …
Phase 3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New hope for young hodgkin patients: drug combo aims to cut radiation
Disease control Recruiting nowThis study is testing a drug called brentuximab vedotin, combined with chemotherapy, for children, adolescents, and young adults newly diagnosed with classical Hodgkin lymphoma. The goal is to see if this approach can achieve a faster and more complete response, allowing fewer pa…
Phase 2/3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC